Healthy Volunteers Clinical Trial
Official title:
Non-technical Attributes and Surgical Experience: a Cross-sectional Study Comparing Communication Styles and Attitudes in Surgical Staff, Trainees and Applicants
Verified date | December 2023 |
Source | University Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study consists of an analysis of the communication styles and attitudes towards risk and uncertainty (i.e. non-technical attributes) in a surgical population with varying clinical experience. The study aims to investigate the differences and specific patterns in non-technical attributes that may be discerned in these groups and how these non technical attributes develop throughout surgical training.
Status | Enrolling by invitation |
Enrollment | 120 |
Est. completion date | June 2025 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Participant is part of any of the following groups: - Applicant for surgical training in general surgery, orthopedics, urology or plastic surgery. - Trainee in general surgery, orthopedics, urology, plastic surgery. - Staff in general surgery, orthopedics, urology, plastic surgery. - Participant is active at Ghent University Hospital or an affiliated training hospital. No exclusion criteria apply to this study. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Ghent |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Participant communication styles | Communication Styles Inventory-96 scale:Subdomains: Expressiveness (range: 1-5); Preciseness (range: 1-5); Verbal aggressiveness (range: 1-5); Questioningness (range: 1-5); Emotionality (range: 1-5); Impression manipulativeness (range: 1-5) | Rating scale is completed by all groups on study inclusion, after signing informed consent. | |
Primary | Participant attitudes towards uncertainty | Physicians' Reactions to Uncertainty (PRU) scale: Anxiety due to uncertainty (Range: 5-30
); Concern about bad outcomes (3-18); Reluctance to disclose uncertainty to patients (Range: 5-30); Reluctance to disclose mistakes to physicians (Range 2-12) |
Rating scale is completed by all groups on study inclusion, after signing informed consent. For the candidate group, this measure is repeated on a selection day during the surgical selection process, +- 1 - 2 months after study inclusion | |
Primary | Participant attitudes towards taking risks | Physicians' risk attitude (PRA) Scale (Range: 2-12) | Rating scale is completed by all groups on study inclusion, after signing informed consent. For the candidate group, this measure is repeated on a selection day during the surgical selection process, +- 1 - 2 months after study inclusion | |
Secondary | Participant perceived actual health status | Short Form-36 scale (Range: 10-50) | Rating scale is completed by all groups on study inclusion, after signing informed consent. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |